2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

D Farge, C Frere, JM Connors, AA Khorana… - The Lancet …, 2022 - thelancet.com
Summary The International Initiative on Thrombosis and Cancer is an independent
academic working group of experts aimed at establishing global consensus for the treatment …

[HTML][HTML] COVID‐19 anticoagulation recommendations in children

M Loi, B Branchford, J Kim, C Self… - Pediatric blood & …, 2020 - ncbi.nlm.nih.gov
To the Editor: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is often associated with hypercoagulability …

Direct oral anticoagulants for use in paediatrics

J Jaffray, G Young - The Lancet Child & Adolescent Health, 2022 - thelancet.com
With the increasing incidence of thromboembolism in children and improvement in
management for patients with medically complex diseases, expanded availability of safe …

[HTML][HTML] Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: a retrospective cohort study

Y He, J Xu, X Shang, X Fang, C Gao, D Sun… - Frontiers in cellular …, 2022 - frontiersin.org
Intensive care unit (ICU)-acquired infection is a common cause of poor prognosis of sepsis
in the ICU. However, sepsis-associated ICU-acquired infections have not been fully …

COVID-19-induced coagulopathy: Experience, achievements, prospects

L Dubey, O Dorosh, N Dubey, S Doan… - Cardiology …, 2023 - journals.viamedica.pl
The presence of coagulopathy as part of the systemic inflammatory response syndrome is a
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …

Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)

K Thom, AWA Lensing, I Nurmeev, F Bajolle… - Blood …, 2020 - ashpublications.org
Anticoagulant treatment of pediatric central venous catheter–related venous
thromboembolism (CVC-VTE) has not been specifically evaluated. In EINSTEIN-Jr, 500 …

Development of a risk model for pediatric hospital-acquired thrombosis: a report from the Children's Hospital-Acquired Thrombosis Consortium

J Jaffray, B Branchford, N Goldenberg, J Malvar… - The Journal of …, 2021 - Elsevier
Objective To identify pertinent clinical variables discernible on the day of hospital admission
that can be used to assess risk for hospital-acquired venous thromboembolism (HA-VTE) in …

Do antimicrobial and antithrombogenic peripherally inserted central catheter (PICC) materials prevent catheter complications? An analysis of 42,562 hospitalized …

AJ Ullman, RS Paterson, JA Schults… - Infection Control & …, 2022 - cambridge.org
Objective: To examine the effectiveness of antimicrobial and antithrombogenic materials
incorporated into peripherally inserted central catheters (PICCs) to prevent bloodstream …

[HTML][HTML] Central venous catheter–associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice

CH van den Bosch, J Spijkerman, MHWA Wijnen… - Supportive Care in …, 2022 - Springer
Purpose The purpose of this study was to determine the most optimal central venous
catheter (CVC) for pediatric patients with Hodgkin lymphoma (HL) in terms of complications …

In defense of the use of peripherally inserted central catheters in pediatric patients

A Crocoli, S Cesaro, M Cellini… - The Journal of …, 2021 - journals.sagepub.com
Central venous access devices have revolutioned the care of children affected by
malignancies, facilitating management of complex and prolonged infusive therapies …